U.S. Medical Equipment Stock News

NasdaqGS:CASH
NasdaqGS:CASHBanks

Undiscovered Gems in the US Market May 2026

In the last week, the United States market has stayed flat despite being up 27% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks with strong growth potential and solid fundamentals can lead to uncovering hidden opportunities that may not yet be widely recognized.
NasdaqGS:MZTI
NasdaqGS:MZTIFood

Top Dividend Stocks To Consider In May 2026

Over the last 7 days, the United States market has remained flat, yet it has seen an impressive 27% increase over the past year with earnings projected to grow by 17% per annum in the coming years. In this context of robust growth expectations, dividend stocks that offer stability and consistent income can be attractive options for investors seeking to capitalize on these favorable conditions.
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Recent Insider Trading In CrowdStrike Holdings

Recently CrowdStrike Holdings, Inc. ( NASDAQ:CRWD ) shareholders may have taken note that Sameer Gandhi, the Independent Director netted about US$5.8m selling shares at an average price of US$580. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 1.2%. In addition these and other sales discussed below were done to cover tax obligations from RSU awards.
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rethinking Rumble (RUM) Valuation After Q1 Earnings Miss And Ongoing Monetization Challenges

Q1 earnings miss and monetization gap Rumble (RUM) reported first quarter revenue of US$25.46 million compared with US$23.71 million a year ago, while the company’s net loss widened to US$30.27 million and the stock fell 10.2% after results. Management pointed to strong user growth, especially in Rumble Shorts. However, this product is not yet monetized, which continues to weigh on average revenue per user and keeps losses elevated despite higher sales. See our latest analysis for Rumble. The...
NYSE:WD
NYSE:WDDiversified Financial

Walker And Dunlop NYSE WD Valuation Check After Recent Share Price Volatility

Walker & Dunlop (WD) has drawn investor attention after its shares closed at US$49.73, with the move coming against a backdrop of mixed recent returns and steady activity across its core commercial real estate financing segments. See our latest analysis for Walker & Dunlop. Recent trading has been choppy, with a 1-day share price return of 2.66% at US$49.73 following a 90-day share price decline of 23.28% and a 1-year total shareholder return decline of 23.42%. This suggests momentum has been...
NYSE:WH
NYSE:WHHospitality

Is It Time To Reassess Wyndham Hotels & Resorts (WH) After Recent Share Price Pullback?

Wondering if Wyndham Hotels & Resorts at around US$80.90 is offering fair value, a bargain, or something in between? This article walks through the numbers so you can judge for yourself. The stock is up 7.5% year to date but has fallen 10.0% over the past month and is down 3.4% over the past year. These moves can change how investors think about both its potential and its risks. Recent coverage has focused on Wyndham Hotels & Resorts as a key branded hotel player, with attention on how it...
NYSE:CRL
NYSE:CRLLife Sciences

Should Higher Impairments and AI Investments Shape a New Capital Allocation Playbook for Charles River (CRL)?

In May 2026, Charles River Laboratories reported first-quarter revenue of US$995.83 million with a net loss of US$14.84 million, raised full-year GAAP EPS guidance to US$5.35–US$5.85, completed a US$200 million buyback, and detailed higher long-lived asset impairments alongside continued investment in AI-enabled digital pathology and cell therapy testing collaborations. These updates highlight Charles River’s effort to reshape its business mix and efficiency profile, using automation,...